Business/StartupsArticle

Shaires Invests $12 Million in AI Genetics Firm Colossal Biosciences

Venture investor Shaires has committed $12 million to artificial intelligence and genetics company Colossal Biosciences.

LF

Lucas Ferreira · Deals & Startups Desk · 16 Aug 2026 · 1 min read

Share

Shaires Invests $12 Million in AI Genetics Firm Colossal Biosciences

Shaires has completed a $12 million investment in Colossal Biosciences, a company specializing in artificial intelligence and genetics.

Financial terms beyond the headline investment figure were not disclosed in the announcement. Colossal Biosciences applies artificial intelligence technologies within the genetics sector.

Startups Technology Financial Market

This article was produced with AI assistance and edited by a Finance Review Daily journalist.

Share this story

LF

Written by

Lucas Ferreira

Deals & Startups Desk

Lucas covers M&A activity and startup funding rounds, tracking deal structures and valuations to explain what a transaction means for the companies and markets involved.

Market Snapshot

Delayed

EUR/USD1.1584▲ 0.15%GBP/USD1.3554▲ 0.13%USD/CHF0.8119▼ 0.04%BTC/USD63,120.01▲ 0.35%ETH/USD1,888.97▲ 0.69%XAU/USD4,390.61▲ 0.34%

Shaires Invests $12 Million in AI Genetics Firm Colossal Biosciences

Market Snapshot

Related Reading

Jane Street reports $15 billion loss in July linked to Situational Awareness

Iranian commander visits U.S. carrier before its return home

Jane Street reports $15 billion loss amid tech sell-off

How Novara Markets' fund protections fit Mauritius' regulatory system

Brixton Metals completes first tranche of CAD 2.5 mln private placement